|
Title
|
|
|
|
Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia
| |
|
Author
|
|
|
|
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Leukemia. - Baltimore, Md, 1987, currens
| |
|
Publication
|
|
|
|
London
:
Nature publishing group
,
2019
| |
|
ISSN
|
|
|
|
0887-6924
[print]
1476-5551
[online]
| |
|
DOI
|
|
|
|
10.1038/S41375-019-0475-Z
| |
|
Volume/pages
|
|
|
|
33
:10
(2019)
, p. 2531-2535
| |
|
ISI
|
|
|
|
000488517000017
| |
|
Pubmed ID
|
|
|
|
31089249
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|